Skip to Main Navigation
Skip to Page Content

Nomination Summary for Clorazepate (N86332)

Nominated Substances: Clorazepate

Nomination Date: 03/31/1986

Nominator: NIEHS, FDA

Rationale: Widespread use including use by pregnant women; development of data on structure-activity relationships with regard to carcinogenic potential; and lack of existing studies.

NTP Principles: Pre 1993 - 3, 4

Status: Selected

Agents and Status

The following information relates to the specific agent and may include history from earlier or later nominations for this same agent.

CASRN: 23887-31-2

Agent Name: Clorazepate

  • No studies are available.